IDH2 GENE MUTATION
Clinical trials for IDH2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH2 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug combo targets brain tumors in young patients
Disease control OngoingThis early-stage trial tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in teens and young adults with a specific type of brain tumor (IDH-mutant glioma). The goal is to find the safest dose and check for side effects. About 78 participants with newly diagnose…
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
New drug probe aims to measure niraparib's brain tumor penetration
Knowledge-focused OngoingThis early-stage trial enrolls 16 adults with recurrent IDH-mutant gliomas who are scheduled for surgery. Participants take niraparib for one month before their operation so researchers can measure how much drug reaches the tumor and how it affects cancer cells. The goal is to ga…
Matched conditions: IDH2 GENE MUTATION
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC